Russell Investments Group
IART icon

Russell Investments Group’s Integra LifeSciences IART Stock Holding History

Russell Investments Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52K Sell
5,523
-473
-8% -$5.19K ﹤0.01% 3306
2025
Q4 		$74.5K Sell
5,996
-15
-0.2% -$199 ﹤0.01% 3158
2025
Q3 		$86.1K Sell
6,011
-49,210
-89% -$674K ﹤0.01% 3079
2025
Q2 		$678K Sell
55,221
-20,699
-27% -$301K ﹤0.01% 2228
2025
Q1 		$1.67M Sell
75,920
-32,970
-30% -$775K ﹤0.01% 1801
2024
Q4 		$2.47M Buy
108,890
+23,788
+28% +$519K ﹤0.01% 1563
2024
Q3 		$1.55M Buy
85,102
+27,535
+48% +$638K ﹤0.01% 1818
2024
Q2 		$1.68M Buy
57,567
+7,065
+14% +$210K ﹤0.01% 1726
2024
Q1 		$1.79M Buy
50,502
+3,743
+8% +$150K ﹤0.01% 1704
2023
Q4 		$2.04M Sell
46,759
-2,875
-6% -$113K ﹤0.01% 1607
2023
Q3 		$1.9M Buy
49,634
+3,027
+6% +$127K ﹤0.01% 1578
2023
Q2 		$1.92M Sell
46,607
-30,895
-40% -$1.49M ﹤0.01% 1589
2023
Q1 		$4.45M Sell
77,502
-1
-0% -$56 0.01% 1165
2022
Q4 		$4.35M Sell
77,503
-146
-0.2% -$7.43K 0.01% 1168
2022
Q3 		$3.29M Buy
77,649
+30,919
+66% +$1.58M 0.01% 1287
2022
Q2 		$2.52M Hold
46,730
– – 0.01% 1467
2022
Q1 		$3M Sell
46,730
-4,482
-9% -$295K 0.01% 1424
2021
Q4 		$3.43M Hold
51,212
– – 0.01% 1491
2021
Q3 		$3.51M Sell
51,212
-424
-0.8% -$30K 0.01% 1464
2021
Q2 		$3.52M Sell
51,636
-29,960
-37% -$2.12M 0.01% 1574
2021
Q1 		$5.63M Sell
81,596
-7,602
-9% -$515K 0.01% 1301
2020
Q4 		$5.79M Sell
89,198
-6,972
-7% -$375K 0.01% 1156
2020
Q3 		$4.54M Buy
96,170
+8,341
+9% +$397K 0.01% 1187
2020
Q2 		$4.13M Buy
87,829
+30,162
+52% +$1.48M 0.01% 1210
2020
Q1 		$2.57M Buy
57,667
+6,530
+13% +$343K 0.01% 1336
2019
Q4 		$2.98M Sell
51,137
-7,441
-13% -$443K 0.01% 1503
2019
Q3 		$3.52M Sell
58,578
-17,749
-23% -$1.06M 0.01% 1376
2019
Q2 		$4.26M Sell
76,327
-110,550
-59% -$5.69M 0.01% 1305
2019
Q1 		$10.4M Sell
186,877
-28,333
-13% -$1.44M 0.02% 880
2018
Q4 		$9.7M Sell
215,210
-26,308
-11% -$1.44M 0.02% 828
2018
Q3 		$15.9M Buy
241,518
+81,358
+51% +$5.06M 0.03% 692
2018
Q2 		$10.3M Sell
160,160
-36,838
-19% -$2.28M 0.02% 896
2018
Q1 		$10.9M Buy
196,998
+1,041
+0.5% +$54.6K 0.02% 931
2017
Q4 		$9.63M Buy
195,957
+30,820
+19% +$1.51M 0.02% 1016
2017
Q3 		$8.34M Sell
165,137
-3,238
-2% -$166K 0.01% 1037
2017
Q2 		$9.18M Sell
168,375
-76,549
-31% -$3.66M 0.02% 955
2017
Q1 		$10.3M Sell
244,924
-41,436
-14% -$1.77M 0.02% 855
2016
Q4 		$12.3M Buy
+286,360
New +$11.6M 0.02% 753

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Investments Group's IART Position: Q1 2026 in Review

Russell Investments Group reduced its Integra LifeSciences (IART) stake by 7.9% in Q1 2026, selling an estimated $5.19K and leaving 5,523 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #3306.

Russell Investments Group first reported a position in IART in Q4 2016 and has held it in 38 quarters since. The position peaked at $15.9M in Q3 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Russell Investments Group held 5,523 shares of Integra LifeSciences worth $52K as of Q1 2026.
  • Russell Investments Group sold 473 Integra LifeSciences shares in Q1 2026, an estimated $5.19K.
  • Integra LifeSciences made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3306 holding.
  • Russell Investments Group first reported a position in Integra LifeSciences in Q4 2016 and has held it in 38 quarters since.
  • Russell Investments Group's Integra LifeSciences position peaked at $15.9M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.